# OnCo record mei-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mei-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mei-pharma" ;
  schema:name "MEI Pharma"@en ;
  schema:alternateName "MEI Pharma, Inc."@en ;
  schema:description "MEI Pharma is a San Diego company whose PI3K-delta inhibitor zandelisib for follicular lymphoma was dropped in 2022 after the FDA signalled it would need a randomised trial, following the class-wide safety review of PI3K inhibitors."@en ;
  schema:url <https://onco.cc/companies/mei-pharma/>, <https://www.meipharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.meipharma.com>, <https://clinicaltrials.gov/search?lead=MEI%20Pharma> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/pi3k-akt-mtor-inhibitors/> ;
  onco:targets <https://onco.cc/targets/pik3cd/> ;
  onco:companies <https://onco.cc/companies/kyowa-kirin/> .